A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : BCLC

Search Conditions:
Search Keyword : BCLC
Search Method : Exact match.
Research Area:

Abbreviation: BCLC
Appearance Frequency: 771 time(s)
Long forms: 9

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
Barcelona Clinic Liver Cancer
(749 times)
(242 times)
HCC (671 times)
OS (188 times)
TACE (171 times)
1999 Prognosis of hepatocellular carcinoma: the BCLC staging classification.
Barcelona Clinic Liver Cancer Classification
(8 times)
(3 times)
HCC (8 times)
TACE (3 times)
CLIP (2 times)
2011 Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.
Breast Cancer Linkage Consortium
(5 times)
(4 times)
BC (2 times)
AR (1 time)
CI (1 time)
1999 Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
Barcelona Liver Clinic
(3 times)
General Surgery
(1 time)
HCC (3 times)
OS (2 times)
AIC (1 time)
2016 Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B.
Barcelona Cancer of the Liver Clinic
(2 times)
(2 times)
HCC (1 time)
RFA (1 time)
SR (1 time)
2011 Hepatocellular carcinoma: screening and staging.
Barcelona Classification
(1 time)
(1 time)
--- 2004 Diagnosis, staging and treatment of hepatocellular carcinoma.
Barcelona classification of liver cancer
(1 time)
(1 time)
HCC (1 time)
JIS (1 time)
Barcelona Liver Cancer Clinic
(1 time)
Liver Neoplasms
(1 time)
HBV (1 time)
HCC (1 time)
NAFLD (1 time)
2019 NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization.
Barcelona Liver Clinic Cancer
(1 time)
(1 time)
ALBI (1 time)
CPC (1 time)
HCC (1 time)
2017 Albumin-Bilirubin and Platelet-Albumin-Bilirubin Grades Accurately Predict Overall Survival in High-Risk Patients Undergoing Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma.